Search Results

US BioTek Laboratories (“US BioTek”), a Clinical Laboratory Improvement Amendments (CLIA) and CAP accredited laboratory, announces the acquisition of Dallas, TX-based RealTime Laboratories (“RealTime”), a pioneer in the field of mycotoxin testing.

Agilent Technologies Inc. (NYSE: A) today announced the addition of water immersion and new confocal spinning disk technology to the BioTek Cytation C10 confocal imaging reader.

US BioTek Laboratories, a leading provider of cutting-edge diagnostic testing services, proudly announces significant expansions to its testing menu in 2023.

Agilent Technologies Inc. (NYSE: A) today announced the release of the Agilent BioTek 406 FX washer dispenser, a compact instrument that combines multifunctional reagent dispensing and plate-washing capabilities.

Nikon Instruments Inc. is pleased to announce that they have entered into a partnership with Lunaphore, part of Bio-Techne Corporation’s Spatial Biology Division, to expand access to spatial biology services with the COMET™ platform for US-based biotech, pharma, and academic customers.

Bio-Techne Corporation is pleased to announce that Lunaphore, part of Bio-Techne’s Spatial Biology Division, is partnering with Nikon Instruments Inc. to expand access to spatial biology services with the COMET™ platform for US-based biotech, pharma, and academic customers.

Enpro Inc. announced that it has entered into a definitive agreement to acquire Advanced Micro Instruments, Inc., a leading provider of highly-engineered, application-specific analyzers and sensing technologies that monitor critical parameters to maintain infrastructure integrity, enable process efficiency, enhance safety, and facilitate the clean energy transition.

Hudson Robotics and Art Robbins Instruments (“Hudson” or “HR”), a global laboratory automation solutions provider, and Argosy Healthcare Partners portfolio company, has acquired Tomtec Inc. (“Tomtec”).

BioPharmaSpec, the leading global Contract Research Organization for discovery and preclinical characterization of biopharmaceuticals, has made major new investments in instrumentation, including top-of-the-range Mass Spectrometers, to support its clients in their product development goals.

Sysmex America, Inc. announces its plan to sell hemostasis instruments and reagents to laboratories in the United States beginning in April, under the company’s mutual OEM agreement with Siemens Healthineers.